Close Menu

NEW YORK (GenomeWeb News) – The National Institute of Dental and Craniofacial Research plans to award up to $5 million next year for basic, translational, and preclinical studies aiming to discover the epigenetic basis of oral diseases that are caused by viruses.

These projects will demonstrate how epigenomic modifications in hosts and in viruses can cause changes in oral cells and tissues that result in oral diseases.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.